LC-MS/MS determination of Synercid® injections
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 32 (6), 1167-1174
- https://doi.org/10.1016/s0731-7085(03)00231-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Stability study of the anticonvulsant enaminone (E118) using HPLC and LC–MSJournal of Pharmaceutical and Biomedical Analysis, 2002
- Synthesis, spectroscopic characterization, stability assessment and DNA-binding of new 2,6-piperidinedione derivativesIl Farmaco, 2001
- Determination of linezolid in human plasma by LC-MS-MSThe Analyst, 2001
- Liquid chromatographic–mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokineticsJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- High-performance liquid chromatography–mass spectrometric analysis of furosemide in plasma and its use in pharmacokinetic studiesIl Farmaco, 2000
- Development and validation of a high-performance liquid chromatographic stability-indicating method for the analysis of Synercid® in quality control, stability and compatibility studiesJournal of Pharmaceutical and Biomedical Analysis, 1999
- Simultaneous high-performance liquid chromatographic determination of quinupristin, dalfopristin and their main metabolites in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476)European Journal of Clinical Microbiology & Infectious Diseases, 1994